/VTR
VTR Stock - Ventas, Inc.
Real Estate|REIT - Healthcare FacilitiesNYSE
$79.10-1.02%
$0.81 (-1.02%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.78
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).64
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.88
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+7.0%upside
Target: $84.64
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VTR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$78.31 – $79.89
TARGET (TP)$84.67
STOP LOSS$72.77
RISK/REWARD1:0.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.79
52W High$81.89
52W Low$56.68
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.92B | $4.50B | $4.13B | $3.83B | $3.80B |
| Gross Profit | $2.10B | $1.94B | $1.85B | $1.74B | $1.86B |
| Gross Margin | 42.6% | 43.1% | 44.7% | 45.4% | 48.9% |
| Operating Income | $681.23M | $415.51M | $483.85M | $421.43M | $591.44M |
| Net Income | $81.15M | $-40,973,000 | $-47,447,000 | $49.01M | $439.15M |
| Net Margin | 1.6% | -0.9% | -1.1% | 1.3% | 11.6% |
| EPS | $0.20 | $-0.10 | $-0.13 | $0.13 | $1.18 |
Company Overview
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Visit WebsiteRating Distribution
Strong Buy
1
5%
Buy / Outperform
13
68%
Hold / Neutral
5
26%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
14 Bullish5 Neutral/Bearish
Price Targets
$56
Average Target
↓ 28.8% Downside
Now
$38
Low
$56
Average
$77
High
Based on 23 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 1st 2025 | Cantor Fitzgerald | Initiation | Overweight | $77 |
| September 19th 2025 | UBS | Initiation | Neutral | $73 |
| June 23rd 2025 | JP Morgan | Upgrade | Overweight | $72 |
| March 7th 2025 | Argus | Upgrade | Buy | - |
| January 17th 2025 | Robert W. Baird | Upgrade | Outperform | $65← $66 |
| October 1st 2024 | Wells Fargo | Upgrade | Overweight | $71← $61 |
| March 18th 2024 | Evercore ISI | Upgrade | Outperform | $50 |
| February 26th 2024 | Wells Fargo | Downgrade | Equal Weight | $46← $52 |
| January 30th 2024 | Deutsche Bank | Initiation | Buy | $60 |
| January 16th 2024 | BofA Securities | Upgrade | Buy | $53← $48 |
| November 7th 2023 | Wedbush | Upgrade | Outperform | $51← $44 |
| October 11th 2023 | Exane BNP Paribas | Initiation | Outperform | $47 |
| October 3rd 2023 | Wedbush | Initiation | Neutral | $44 |
| September 20th 2023 | Raymond James | Downgrade | Outperform | $53← $55 |
| August 11th 2023 | BofA Securities | Downgrade | Neutral | $48← $54 |
Earnings History & Surprises
VTRBeat Rate
72%
Last 18 quarters
Avg Surprise
+227.3%
EPS vs Estimate
Beats / Misses
13/1
4 met exactly
Latest EPS
$0.88
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.76vs$0.76
Q2 24
+5.4%
$0.78vs$0.74
Q3 24
+1.3%
$0.80vs$0.79
Q4 24
0.0%
$0.80vs$0.80
Q1 25
+4150.0%
$0.81vs$-0.02
Q2 25
+2.4%
$0.84vs$0.82
Q3 25
+2.4%
$0.87vs$0.85
Q4 25
+1.1%
$0.88vs$0.87
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $0.89 | — | — | — |
Q4 2025 | Oct 29, 2025 | $0.87 | $0.88 | +1.1% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.85 | $0.87 | +2.4% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $0.82 | $0.84 | +2.4% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $-0.02 | $0.81 | +4150.0% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.80 | $0.80 | 0.0% | = MET |
Q3 2024 | Aug 1, 2024 | $0.79 | $0.80 | +1.3% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $0.74 | $0.78 | +5.4% | ✓ BEAT |
Q1 2024 | Feb 14, 2024 | $0.76 | $0.76 | 0.0% | = MET |
Q4 2023 | Nov 2, 2023 | $0.74 | $0.75 | +1.4% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.74 | $0.75 | +1.4% | ✓ BEAT |
Q2 2023 | May 8, 2023 | $0.70 | $0.74 | +5.7% | ✓ BEAT |
Q1 2023 | Feb 9, 2023 | $0.72 | $0.73 | +1.4% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $6.19 | $0.76 | -87.7% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $0.72 | $0.72 | 0.0% | = MET |
Q2 2022 | May 5, 2022 | $0.77 | $0.79 | +2.6% | ✓ BEAT |
Q1 2022 | Feb 17, 2022 | $0.71 | $0.73 | +2.8% | ✓ BEAT |
Q4 2021 | Nov 5, 2021 | $0.73 | $0.73 | 0.0% | = MET |
Q3 2021 | Aug 6, 2021 | $0.72 | $0.73 | +1.4% | ✓ BEAT |
Latest News
Keybanc Maintains Overweight on Ventas, Raises Price Target to $85
📈 PositiveBenzinga•Dec 4, 2025, 01:20 PM
Wells Fargo Maintains Overweight on Ventas, Raises Price Target to $88
📈 PositiveBenzinga•Nov 25, 2025, 05:07 PM•Also:
Scotiabank Maintains Sector Perform on Ventas, Raises Price Target to $80
➖ NeutralBenzinga•Nov 13, 2025, 06:06 PM
Citigroup Maintains Buy on Ventas, Raises Price Target to $88
📈 PositiveBenzinga•Nov 11, 2025, 08:30 PM•Also:
Live On CNBC, Josh Brown Hosts Segment Titled "Best Stocks In The Market: Welltower; Ventas "
📈 PositiveBenzinga•Nov 7, 2025, 05:40 PM•Also:
Cantor Fitzgerald Maintains Overweight on Ventas, Raises Price Target to $85
📈 PositiveBenzinga•Oct 31, 2025, 01:26 PM
Ventas shares are trading higher after the company reported better-than-expected Q3 FFO and sales.
📈 PositiveBenzinga•Oct 30, 2025, 03:52 PM
Ventas Raises FY2025 Normalized FFO Guidance from $3.41-$3.46 to $3.45-$3.48 vs $3.46 Est
📈 PositiveBenzinga•Oct 29, 2025, 08:12 PM
Ventas Q3 FFO $0.88 Beats $0.87 Estimate, Sales $1.489B Beat $1.426B Estimate
📈 PositiveBenzinga•Oct 29, 2025, 08:11 PM
Wells Fargo Maintains Overweight on Ventas, Raises Price Target to $80
📈 PositiveBenzinga•Oct 21, 2025, 01:24 PM
Cantor Fitzgerald Initiates Coverage On Ventas with Overweight Rating, Announces Price Target of $77
📈 PositiveBenzinga•Oct 1, 2025, 02:13 PM
UBS Initiates Coverage On Ventas with Neutral Rating, Announces Price Target of $73
➖ NeutralBenzinga•Sep 19, 2025, 02:37 PM
Evercore ISI Group Maintains Outperform on Ventas, Raises Price Target to $80
📈 PositiveBenzinga•Sep 15, 2025, 02:21 PM
Scotiabank Maintains Sector Perform on Ventas, Raises Price Target to $74
📈 PositiveBenzinga•Aug 28, 2025, 04:50 PM
JP Morgan Maintains Overweight on Ventas, Raises Price Target to $76
📈 PositiveBenzinga•Aug 26, 2025, 03:46 PM•Also:
Argus Research Reiterates Buy on Ventas, Maintains $75 Price Target
📈 PositiveBenzinga•Aug 26, 2025, 01:40 PM
Raymond James Reiterates Outperform on Ventas, Raises Price Target to $78
📈 PositiveBenzinga•Aug 22, 2025, 01:02 PM
Frequently Asked Questions about VTR
What is VTR's current stock price?
Ventas, Inc. (VTR) is currently trading at $79.10 per share. The stock has moved -1.02% today.
What is the analyst price target for VTR?
The average analyst price target for VTR is $84.67, based on 1 analyst.
What sector is Ventas, Inc. in?
Ventas, Inc. operates in the Real Estate sector, specifically within the REIT - Healthcare Facilities industry. The company is traded on the NYSE exchange.
What is VTR's market cap?
Ventas, Inc. has a market capitalization of $35.00 billion, making it a large-cap company.
Does VTR pay dividends?
No, Ventas, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Real Estate SectorAVB
AvalonBay Communities, Inc.
$179.13
Mkt Cap: $25.5B
CCI
Crown Castle Inc.
$86.10
Mkt Cap: $37.5B
CSGP
CoStar Group, Inc.
$65.23
Mkt Cap: $27.6B
DOC
Healthpeak Properties, Inc.
$15.99
Mkt Cap: $11.1B
EQR
Equity Residential
$61.37
Mkt Cap: $23.3B
EXR
Extra Space Storage Inc.
$130.07
Mkt Cap: $27.6B
IRM
Iron Mountain Incorporated
$80.09
Mkt Cap: $23.7B
OHI
Omega Healthcare Investors, Inc.
$43.97
Mkt Cap: $13.0B
SBAC
SBA Communications Corporation
$190.01
Mkt Cap: $20.4B
VICI
VICI Properties Inc.
$27.70
Mkt Cap: $29.6B
Explore stocks similar to VTR for comparison